HGH Health News > HGH Secretagogue.
Human
Growth Hormone Replacement Therapy Using a Pre-Cursor Secretagogue
Analog (Sermorelin)
A Secretagogue is a substance that promotes secretion or
release, for instance the Secretagogue for Human Growth Hormone
production, ie. The substance that tells your pituitary gland to
increase HGH production is GHRH (growth Hormone Releasing Hormone).
Sermorelin is a polypeptide chain that mimics the effects of Growth
Hormone Releasing Hormone – the substances that naturally
tells your pituitary gland to increase HGH production.
Growth Hormone Releasing Hormone (GHRH) Therapy:
Sermorelin, is a Human Growth Hormone HGH “Secretagogue”
delivered through subcutaneous Injection - GH-RH (1-29)
Growth hormone deficiency
in adults occurs when the naturally occurring pituitary hormone
known as Human Growth Hormone is produced in inadequate quantities
with a resulting deficiency in growth hormone and IGF-1 levels in
the blood stream. Growth hormone deficiency includes a spectrum
that ranges from a complete lack of growth hormone through various
degrees of partial growth hormone deficiency. Most people after
the age of 25 to 30 begin a process of human growth hormone deficiency
that accelerates at a loss rate of 1 to 2% per year, depending on
ones own genetic makeup, diet, exercise and lifestyle.
In contrast to supplementing the growth hormone deficiency through
injections of exogenous recombinant Human Growth Hormone (HGH),
another therapy, GH-RH therapy involves the use of GH-RH injections
that cause the body’s pituitary gland to secrete greater quantities
of naturally produced Human Growth Hormone. The body therefore naturally
produces its own growth hormone to supplement the deficiency as
a result of GH-RH therapy.
See: HGH
Sermorelin
Your Human Growth
Hormone Status
|
